3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Polycythemia Vera
3
Venous Thromboembolism
2
Thrombocythemia, Essential
2
Rectal Neoplasms
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Adenoma
2
Vascular Diseases
1
Thrombosis
1
Thrombocytopenia
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Pathologic Processes
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lynch syndrome I (site-specific colonic cancer)
1
Lymphoma, Follicular
1
Liver Cirrhosis
1
Ischemic Stroke
1
Interventions
Cisplatin
8
Radiotherapy
5
Paclitaxel
5
Docetaxel
5
Cetuximab
4
Carboplatin
4
pembrolizumab
3
figitumumab
2
cemiplimab
2
advexin
2
Radiation
2
Methotrexate
2
Fluorouracil
2
Drug Therapy
2
Bleomycin
2
vandetanib
1
talimogene laherparepvec
1
sintilimab
1
nedaplatin
1
nanocis
1
methyl 5-aminolevulinate
1
ficlatuzumab
1
dusquetide
1
brigatinib
1
avasopasem manganese
1
alpha-2'-deoxythioguanosine
1
Vinorelbine
1
Tretinoin
1
Tirapazamine
1
Technetium-99
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Squamous Cell
×
Aspirin
×
Clear all
NCT01496521
2011-12-21
CREAT
Beijing Friendship Hospital
Phase 3
Unknown
600 enrolled